[Focus on systemic sclerosis].Dtsch Med Wochenschr 2026 Jun; 151(12):645-651.DM
Abstract
Systemic sclerosis is one of the most challenging autoimmune connective tissue diseases. 2024 new treatment recommendations were published by EULAR which now are amended by German recommendations for diagnostic and therapy. This overview article focuses on these new advices to help referring physicians to identify patients with typical clinical features earlier and thus to improve early diagnosis and future treatment options. Here, especially (but not solely) B-cell targeting therapies are in the scope.
Pub Type(s)
Journal Article
Review
English Abstract
Language
ger
PubMed ID
42214365
Citation
Henes, Jörg, and Ann-Christin Pecher. "[Focus On Systemic Sclerosis]." Deutsche Medizinische Wochenschrift (1946), vol. 151, no. 12, 2026, pp. 645-651.
Henes J, Pecher AC. [Focus on systemic sclerosis]. Dtsch Med Wochenschr. 2026;151(12):645-651.
Henes, J., & Pecher, A. C. (2026). [Focus on systemic sclerosis]. Deutsche Medizinische Wochenschrift (1946), 151(12), 645-651. https://doi.org/10.1055/a-2676-2759
Henes J, Pecher AC. [Focus On Systemic Sclerosis]. Dtsch Med Wochenschr. 2026;151(12):645-651. PubMed PMID: 42214365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Focus on systemic sclerosis].
AU - Henes,Jörg,
AU - Pecher,Ann-Christin,
Y1 - 2026/05/29/
PY - 2026/5/30/medline
PY - 2026/5/30/pubmed
PY - 2026/5/29/entrez
SP - 645
EP - 651
JF - Deutsche medizinische Wochenschrift (1946)
JO - Dtsch Med Wochenschr
VL - 151
IS - 12
N2 - Systemic sclerosis is one of the most challenging autoimmune connective tissue diseases. 2024 new treatment recommendations were published by EULAR which now are amended by German recommendations for diagnostic and therapy. This overview article focuses on these new advices to help referring physicians to identify patients with typical clinical features earlier and thus to improve early diagnosis and future treatment options. Here, especially (but not solely) B-cell targeting therapies are in the scope.
SN - 1439-4413
UR - https://www.unboundmedicine.com/prime/citation/42214365/[Focus_on_systemic_sclerosis].
DB - PRIME
DP - Unbound Medicine
ER -
